CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 121 filers reported holding CTI BIOPHARMA CORP in Q2 2022. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $203 | -47.8% | 48,323 | -25.4% | 0.00% | -100.0% |
| Q4 2022 | $389 | -99.9% | 64,753 | +0.1% | 0.00% | 0.0% |
| Q3 2022 | $377,000 | -1.0% | 64,700 | +1.3% | 0.00% | – |
| Q2 2022 | $381,000 | +958.3% | 63,900 | +71.3% | 0.00% | – |
| Q1 2019 | $36,000 | +33.3% | 37,300 | 0.0% | 0.00% | – |
| Q4 2018 | $27,000 | -66.7% | 37,300 | 0.0% | 0.00% | – |
| Q3 2018 | $81,000 | -56.5% | 37,300 | 0.0% | 0.00% | – |
| Q2 2018 | $186,000 | – | 37,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|